PD1-Vaxx is being considered for other tumor indications besides NSCLC. This is exciting. If it can treat more than NSCLC, then its market size had just grown exponentially.
More importantly, it is well tolerated and showing early efficacy. Can't be happier with that!
- Forums
- ASX - By Stock
- IMU
- Ann: PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting
Ann: PD1-Vaxx Presentation at ESMO Congress 2021 Annual Meeting, page-13
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1925982 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 3452098 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1925982 | 0.048 |
33 | 4297134 | 0.047 |
47 | 3841303 | 0.046 |
53 | 6064000 | 0.045 |
11 | 2329545 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 2620667 | 8 |
0.050 | 2639213 | 14 |
0.051 | 6431004 | 11 |
0.052 | 2071350 | 7 |
0.053 | 418882 | 5 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |